Julie Cartwright

Julie Cartwright is the President of Pvolve, a science-led fitness method that pairs low-impact, functional movement and patented resistance equipment to sculpt the body without the wear and tear of high-impact exercise. Through its hybrid fitness model, Pvolve can be experienced globally on-demand through live and virtual classes, and in both brand-owned and growing franchise studio locations. 

Julie joined as President at Pvolve’s founding and has led the brand’s expanding footprint within the fitness space, growing the business from a small startup to a global female-led fitness authority, complete with live virtual classes, expansive on-demand programming, patented equipment, and a growing number of studio locations. 

As President, Julie is responsible for spearheading Pvolve’s overall vision and growth strategy while achieving financial objectives and setting investment priorities for the business.   

An avid Pvolve user herself, Cartwright can often be found at the Chicago studio location or taking classes online through the Live Virtual Studio. 

Amanda Raad

Alison Geary

Alison's practice focuses on corporate crime involving fraud, bribery, corruption, market abuse, cartels and money laundering. She acts in Serious Fraud Office (SFO), Financial Conduct Authority (FCA) and World Bank investigations. She has extensive experience in advising UK companies and individuals subject to investigation by international authorities. She assists organisations in achieving negotiated settlements with the authorities and has also represented individuals in many high-profile investigations. She has previously acted for high-profile individuals in the SFO's investigations into foreign exchange benchmark manipulation, LIBOR manipulation, corruption in the mining industry and corruption in the aviation sector, as well as the investigation by the Metropolitan Police into phone hacking.

Marija Butkovic

Karen Silverman

Karen is a leading global expert in practical governance strategies for AI and other frontier technologies. As the CEO and Founder of The Cantellus Group, she advises Fortune 50 companies, startups, consortia, and the public sector on how to manage cutting-edge technologies in a rapidly changing policy environment. Her expertise is informed by more than 20 years of practice and management leadership at Latham & Watkins, LLP where she advised global businesses in complex antitrust matters, M&A, governance, ESG, and crisis management. Karen chairs the board of a public benefit corporation developing complex content moderation tools. She is an SME for the Business Roundtable's Responsible AI Initiative, and a World Economic Forum Global Innovator and Karen sits on its Global AI Council. She serves on the boards of Krunam, AI.EDU, Legal Momentum and Not For Sale.

Farah Anwar

Farah Anwar is the Head of Clinical Development Operations at Sana and serves as the Leader of Inclusion, Diversity and Equity.

Farah has been chairing Sana’s diversity committee, Voices at Sana since it’s inception in 2018.  She was most recently Vice President, Clinical Operations at Juno Therapeutics.  Previously she was Executive Director, Global Commercial Planning at Ultragenyx Pharmaceuticals where she helped build out the Global Commercial organization and served as Chief of Staff to the Chief Commercial Officer.

Farah served in various roles in strategic operations and study management at Genentech including Head of Study Management for Immunology, Infectious Disease, Ophthalmology and Neuroscience overseeing 15 products in various phases of development and 100+ clinical trials. Earlier in her career, Farah was at MedImmune where she started in Medical Affairs then worked as a Clinical Program Lead in Development working on infectious disease programs.

Farah holds a BS in Physical Therapy from the University of Maryland, a MS in Clinical Research Administration from the George Washington University and a certificate in Inclusion, Diversity and Equity from Cornell University.